Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

MedMira Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Post by TanzaniteMotherLodeon Aug 29, 2020 7:05pm
229 Views
Post# 31475894

MIR's test is a total antibody test - VERY IMPORTANT

MIR's test is a total antibody test - VERY IMPORTANTLimited information is currently available to completely characterize COVID-19 disease. Based on what is known about the virus that causes COVID-19 (i.e. SARS-CoV- 2), signs and symptoms may appear any time from 2 to 14 days after exposure to the virus. According to the preliminary data, the median incubation period is approximately 5 days, but may range anywhere from 2 to 14 days. Antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection. Limited scientific evidence is available to definitively tell how long or what class of antibodies to SARS-CoV-2 will remain present in the body after infection. Detection of total antibodies to SARS-CoV-2 may reduce the number of false negative samples identified by the class-specific tests.

Scroll down to FAQ and see #10 

https://revealcovid19.com/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities